C267-0039 Screening compound: N-[2-(4-ethylpiperazin-1-yl)-4-methylquinolin-6-yl]-4-(2-fluorophenyl)piperazine-1-carbothioamide

C267-0039 Screening compound: N-[2-(4-ethylpiperazin-1-yl)-4-methylquinolin-6-yl]-4-(2-fluorophenyl)piperazine-1-carbothioamide
C267-0039 Screening compound: N-[2-(4-ethylpiperazin-1-yl)-4-methylquinolin-6-yl]-4-(2-fluorophenyl)piperazine-1-carbothioamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C267-0039
N-[2-(4-ethylpiperazin-1-yl)-4-methylquinolin-6-yl]-4-(2-fluorophenyl)piperazine-1-carbothioamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C267-0039

Molecular Formula

C27H33FN6S (C27 H33 FN6 S)

Compound Name

N-[2-(4-ethylpiperazin-1-yl)-4-methylquinolin-6-yl]-4-(2-fluorophenyl)piperazine-1-carbothioamide

IUPAC name

N-[2-(4-ethylpiperazin-1-yl)-4-methylquinolin-6-yl]-4-(2-fluorophenyl)piperazine-1-carbothioamide

SMILES

CCN(CC1)CCN1c1cc(C)c(cc(cc2)NC(N(CC3)CCN3c(cccc3)c3F)=S)c2n1

InChI

InChI=1S/C27H33FN6S/c1-3-31-10-12-33(13-11-31)26-18-20(2)22-19-21(8-9-24(22)30-26)29-27(35)34-16-14-32(15-17-34)25-7-5-4-6-23(25)28/h4-9,18-19H,3,10-17H2,1-2H3,(H,29,35)

InChI Key

FULWIWRWOXIENS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD03829736

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

492.66

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.671

Distribution Coefficient, logD

4.984

Water Solubility, LogSw

-5.69

Polar Surface Area

28.880

Acid Dissociation Constant (pKa)

13.71

Base Dissociation Constant (pKb)

7.99

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.70

C267-0039 in Drug Discovery

Included in Screening Libraries

Autophagy-Targeted Library (4564 compounds)

Human GPCR Annotated Library (5539 compounds)

SmartTM Library (51161 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system

References: we are preparing a list of scientific research reports with C267-0039 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C267-0039?
Check Price and Availability of C267-0039, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C267-0039 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C267-0039
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C267-0039
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C267-0039 available by request